The Federal Court of Appeal recently released an interesting decision at the intersection of constitutional and administrative law in Galderma Canada Inc. v. Canada (Attorney General), 2024 FCA 208 (I was co-counsel for the appellant). The case involved a judicial review of a decision of the Patented Medicines Prices Review Board purporting to regulate an […]
